Rorze

Rorze EBITDA per Share

The EBITDA per Share of Rorze (6323.T) as of Nov 3, 2026 is 179.64 JPY. In the previous year, EBITDA per Share was 187.19 JPY — a change of -4.04% (lower).

EBITDA per Share

179.64JPY

YoY

-4.04%

Last updated:

EBITDA per Share of Rorze is 2026 179.64 JPY. EBITDA per Share of Rorze was 2025 187.19 JPY. It decreases by -4.04% lower compared to the previous year.

The Rorze EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
34.30 JPY
Jan 1, 2020
45.70 JPY
Jan 1, 2021
54.95 JPY
Jan 1, 2022
92.57 JPY
Jan 1, 2023
151.23 JPY
Jan 1, 2024
138.75 JPY
Jan 1, 2025
187.19 JPY
Jan 1, 2026
179.64 JPY
The Rorze EBITDA per Share history
YEAREBITDA per ShareYoY
179.64JPY-4.04%
187.19JPY+34.92%
138.75JPY-8.25%
151.23JPY+63.37%
92.57JPY+68.46%
54.95JPY+20.23%
45.70JPY+33.26%
34.30JPY+36.42%
25.14JPY-6.58%
26.91JPY+53.81%
17.50JPY+245.10%
5.07JPY-30.99%
7.35JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rorze Stock analysis

What does Rorze do? Rorze Corp. generates revenue through the sale of automation systems for semiconductor and FPD production. The Semiconductor and FPD-related equipment segment offers products such as EFEM, wafer transporters for atmosphere and vacuum, wafer sorters, stockers for N2 purge, transport units, large glass substrate transporters, glass cutting machines, and stepping motor drivers and controllers. These products are sold to semiconductor and LCD industry clients. The Life Science segment provides cell culture devices including incubators, targeting the drug discovery industry and related fields. Both segments focus on delivering specialized equipment to industrial clients requiring precision manufacturing solutions in their respective markets. The company's primary customers in the semiconductor and FPD sectors are manufacturers of semiconductors and flat panel displays. These clients purchase automation systems to enhance production efficiency and maintain cleanroom standards. In the Life Science segment, pharmaceutical and biotechnology firms buy cell culture devices for research and development purposes. Rorze Corp. serves these segments with tailored equipment designed for high-precision industrial applications. Rorze Corp.'s business model revolves around developing and selling specialized machinery for two key industrial markets. The Semiconductor and FPD-related equipment segment drives the majority of sales with its range of dust-free transport solutions. The Life Science segment complements this by offering cell culture devices that support drug discovery processes. Both segments rely on direct sales to industrial clients seeking advanced automation for their manufacturing and research operations. Rorze is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rorze stock

EBITDA per Share of Rorze is 179.64 JPY in 2026.

EBITDA per Share of Rorze changed from 187.19 JPY to 179.64 JPY, representing a -4.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Rorze since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Rorze

All Key Metrics — Rorze